In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more
8/25/2025
/ Artificial Intelligence ,
Clinical Trials ,
Cybersecurity ,
Digital Health ,
Environmental Social & Governance (ESG) ,
Genetic Materials ,
Government Agencies ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Life Sciences ,
Pharmaceutical Industry ,
Public Health ,
Regulatory Oversight ,
Regulatory Reform ,
Regulatory Requirements ,
Risk Management ,
Supply Chain ,
Trump Administration
When oil prices dropped two years ago, it took a while for the severity and durability of the new oil-price environment to sink in. The response came in 2016: governments focused on cutting expenditure, sending a cascade of...more
1/19/2017
/ Acquisitions ,
Banks ,
Capital Markets ,
Corporate Restructuring ,
Education Reform ,
Foreign Investment ,
Gulf Cooperation Council (GCC) ,
Healthcare ,
Initial Public Offering (IPO) ,
Mergers ,
Oil & Gas ,
Oil Prices ,
Oman ,
Private Equity ,
Saudi Arabia ,
Transportation Industry ,
Venture Capital